Milestone Pharmaceuticals Inc.
MIST
$1.07
-$0.06-4.89%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -84.01M | -68.36M | -63.06M | -58.01M | -55.53M |
| Total Depreciation and Amortization | 753.00K | 724.00K | 695.00K | 647.00K | 647.00K |
| Total Amortization of Deferred Charges | 459.00K | 447.00K | 432.00K | 414.00K | 400.00K |
| Total Other Non-Cash Items | 17.19M | 13.40M | 10.21M | 8.00M | 7.99M |
| Change in Net Operating Assets | 4.32M | 2.65M | 2.68M | 5.84M | 6.12M |
| Cash from Operations | -61.29M | -51.14M | -49.04M | -43.11M | -40.38M |
| Capital Expenditure | -356.00K | -341.00K | -302.00K | -41.00K | -43.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 37.00K | -102.03M | 11.55M | 27.92M | 69.39M |
| Cash from Investing | -319.00K | -102.37M | 11.25M | 27.88M | 69.34M |
| Total Debt Issued | 75.00M | 75.00M | -- | -- | -- |
| Total Debt Repaid | -22.00K | -11.00K | -- | -- | -- |
| Issuance of Common Stock | 111.29M | 102.18M | 82.95M | 46.55M | 274.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 2.57M | 2.57M | 2.57M | 2.57M | 0.00 |
| Cash from Financing | 188.84M | 179.74M | 85.53M | 49.12M | 274.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 127.23M | 26.23M | 47.73M | 33.89M | 29.24M |